AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $91,000 | +23.0% | 9,628 | 0.0% | 0.00% | – |
Q2 2020 | $74,000 | +23.3% | 9,628 | 0.0% | 0.00% | – |
Q1 2020 | $60,000 | -45.9% | 9,628 | +5.1% | 0.00% | -100.0% |
Q4 2019 | $111,000 | +4.7% | 9,158 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $106,000 | +16.5% | 9,158 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $91,000 | -22.9% | 9,158 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $118,000 | -15.1% | 9,158 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $139,000 | -24.0% | 9,158 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $183,000 | +2.2% | 9,158 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $179,000 | -3.2% | 9,158 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $185,000 | +52.9% | 9,158 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $121,000 | -28.4% | 9,158 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $169,000 | 0.0% | 9,158 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $169,000 | -18.4% | 9,158 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $207,000 | -35.1% | 9,158 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $319,000 | +41.2% | 9,158 | -0.7% | 0.00% | +50.0% |
Q3 2016 | $226,000 | +2.3% | 9,227 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $221,000 | +2.3% | 9,227 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $216,000 | -22.6% | 9,227 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $279,000 | -24.0% | 9,227 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $367,000 | -42.4% | 9,227 | 0.0% | 0.00% | -40.0% |
Q2 2015 | $637,000 | +26.4% | 9,227 | 0.0% | 0.01% | +25.0% |
Q1 2015 | $504,000 | +10.5% | 9,227 | -13.8% | 0.00% | 0.0% |
Q4 2014 | $456,000 | +33.3% | 10,709 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $342,000 | +54.1% | 10,709 | 0.0% | 0.00% | +50.0% |
Q2 2014 | $222,000 | +7.2% | 10,709 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $207,000 | -20.4% | 10,709 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $260,000 | +13.0% | 10,709 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $230,000 | -3.4% | 10,709 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $238,000 | – | 10,709 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |